Free Cash Flow

ChemoCentryx Inc (CCXI)

$ 10.7
-0.27 (-2.46%)

Free Cash Flow

Year
A/P
2013
Actual
2014
Projected
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 6.06------------
Revenue (%)
Operating Cash Flow -33.32------------
Operating Cash Flow (%)
Capital Expenditure -0.55------------
Capital Expenditure (%)
Free Cash Flow -33.87------------

FCF Unlevered from cash flow statement